comparemela.com

Latest Breaking News On - Alerje inc - Page 2 : comparemela.com

Epinephrine Market To Reach USD 4 76 Billion By 2028

Alerje Announces Phase 1 SBIR Grant Award From The National Science Foundation (NSF), Simplifying Food Allergy Oral Immunotherapy (OIT)

Press release content from Business Wire. The AP news staff was not involved in its creation. Alerje Announces Phase 1 SBIR Grant Award From The National Science Foundation (NSF), Simplifying Food Allergy Oral Immunotherapy (OIT) July 9, 2021 GMT DETROIT (BUSINESS WIRE) Jul 8, 2021 Alerje, a Detroit based company that develops digital tools for food allergy management, announced today the receipt of a Phase I grant under auspices of the Small Business Innovation Research (SBIR) program of the National Science Foundation. The grant will be utilized to develop an OIT platform that collects, stores, analyses, and distributes clinically relevant data to build a bridge between patients, allergists, & pharma. Alerje’s digital platform possesses various food allergy management features, including improving the efficacy of delivering an OIT regimen for allergists, ensuring successful completion by the patient. This platform will enhance the relationship between an allergist and patien

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.